As the world marks World Malaria Day 2026, it's time to confront the harsh reality that malaria continues to cast a heavy shadow over Africa, despite the progress made in recent years. While the continent has made strides in combating this preventable disease, the battle is far from over. In my opinion, the fight against malaria is not just a health crisis but a defining test of Africa's Health Security and Sovereignty (AHSS).
Malaria's impact on Africa is profound and multifaceted. It's not merely a health issue; it's a constraint on development, weakening human capital, reducing productivity, and deepening poverty. The numbers are staggering: in 2024, Africa accounted for 96% of global malaria cases and 97% of global malaria deaths, with children under 5 and pregnant women being the most vulnerable. This highlights the urgent need for a comprehensive and coordinated response.
One of the key strengths of Africa's malaria control efforts has been the scale-up of various interventions, such as insecticide-treated nets, indoor residual spraying, and artemisinin-based combination therapy. These measures have undoubtedly saved millions of lives. However, the progress is fragile, and the challenges are evolving. Artemisinin partial resistance, for instance, poses a significant threat to the long-term effectiveness of first-line treatment, while insecticide resistance erodes the impact of vector control tools.
What makes this situation particularly fascinating and concerning is the interplay of various factors. Climate change is altering vector habitats, extending transmission seasons, and increasing the frequency of environmental shocks that amplify outbreaks. These pressures are interacting with humanitarian crises, population movement, and financing gaps, making malaria more complex and resilient. The principal challenge is no longer just the availability of commodities but the strength of the systems through which they are delivered.
From my perspective, the current response is exposed by this changing epidemiology. The focus must shift from commodity availability to the robustness of delivery systems. Countries need to be able to deploy prevention, diagnosis, treatment, surveillance, and response rapidly, precisely, and equitably enough to match the resurgent epidemiology of malaria. This is why malaria must be treated as a defining test of Africa's AHSS agenda.
To address this, Africa CDC is taking several crucial steps. First, mobilizing high-level political commitment from African leaders is essential. Africa CDC is uniquely positioned to serve as a convening and coordinating body, rallying political leaders to support the malaria elimination effort. Advocating for high-level political support to translate continental and global strategies into locally adapted actions under African leadership is vital.
Second, strengthening evidence generation on the determinants of malaria resurgence and the underlying drivers of stagnation in the malaria response is essential. This includes understanding emerging threats like artemisinin partial resistance, shifting transmission patterns linked to climate variability, and the effects of conflict on service delivery. By grounding decision-making in robust, context-specific evidence, countries and partners will be better positioned to design differentiated strategies and adapt responses in a timely manner.
Third, coordination of malaria response efforts across the continent is critical. Africa CDC is establishing the African Malaria Response Acceleration Taskforce (AMRAT) to align countries and partners under a single framework. This approach, inspired by the successful Incident Management Support Team (IMST) during the mpox response, aims to bring discipline, accountability, and adaptation to the malaria response.
Fourth, mobilizing community-based systems is key to bridging the gap between strategy and the implementation of proven malaria prevention and control interventions. By leveraging the remaining 1 million community health workers, Africa CDC will guide Member States to improve program efficiency, timely course correction, and the effective translation of technical guidance into measurable outcomes. Digitally enabled and climate-resilient primary health care systems will form the backbone of accelerated malaria control and elimination.
Lastly, the availability and accessibility of malaria prevention and control commodities are indispensable. Expanding local manufacturing and establishing reliable markets through the Africa Pooled Procurement Mechanism are pivotal. This initiative has already borne fruit, as demonstrated by the production of bed nets in Angola.
In conclusion, malaria elimination by 2030 is not just an aspiration but a necessity. It requires African political ownership, evidence-informed decisions, stronger community-based systems, coordinated efforts, and investments in local manufacturing and commodity access. Africa has reached a point where malaria cannot be managed as routine business; it must be confronted as a continental priority with the urgency and discipline that health security demands. If Africa is to lead its own public health future, ending malaria must be part of that leadership. It's time for Africa to take charge and end malaria once and for all.
